Fact CheckerSign in

NCT06464978Recruiting

Stapler Reinforcement Patches Compared to Standard Staplers in Gastrojejunostomy

The Impact of Stapler Reinforcement Patches Compared to Standard Staplers on Postoperative Complications in Gastrojejunostomy: A Multicenter Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 31 Mar 2026

Brief summary (registry, in English)

This is a multi-center, prospective, randomized controlled study aimed at compareing the impact of stapler reinforcement patches versus standard staplers on postoperative complications in gastrojejunostomy.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
382 (estimated)
First submitted
7 Jun 2024
Start date
30 May 2024
Primary completion date
31 Dec 2028
Lead sponsor
Nanchong Central Hospital
NCT number
NCT06464978

What you commit to

  • Study type: Interventional
  • Planned participants: 382
  • From 30 May 2024 to the primary completion date, 31 Dec 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Significant contraindications for surgery (e.g., severe liver or kidney dysfunction).

Other illness

  • History of other malignancies diagnosed within the past 5 years, or any malignancy treated with chemotherapy or radiotherapy.

Other

  • Evidence of potential distant metastasis found preoperatively.
  • Participation in any other clinical trial within the last 6 months.
  • Participants or their legal representatives unwilling to sign the informed consent or comply with the study protocol.

Who the study is looking for

  • Age between 18 and 85 years.
  • Pathologically diagnosed with gastric cancer and suitable for distal gastrectomy or subtotal gastrectomy.
  • ECOG performance status of 0 or 1.
  • ASA (American Society of Anesthesiologists) classification of I-III.
  • Voluntary signed informed consent from the participant or their legal representative.

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Yunhong Tian
Coordinator of this site? Confirm its status
NanchongChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.